10 / 14
Page 65
conferenceseries
.com
Volume 8
Journal of Gastrointestinal & Digestive System
Gastro Meet 2018
August 06-07, 2018
August 06-07, 2018 Abu Dhabi, UAE
Gastroenterology and Digestive
Disorders
16
th
International Conference on
J Gastrointest Dig Syst 2018, Volume 8
DOI: 10.4172/2161-069X-C3-071
Trendy guidelines for the treatment of hepatocelular carcinoma
Gustavo Aguilar M.D
Hospital General San Juan de Dios, Guatemala
D
uring the last years, Hepatocellular Carcinoma has become a public health issue in many countries. It is strongly related to
cirrhosis that´s why surveillance each six months is recommended, than it allows diagnosis at an early stage, when effective
therapies are possible. The best candidates for resection are patients with a solitary tumor and preserved liver function on the
other hand liver transplantation is indicated in patients who are not good candidates for surgical resection, but are still meet in
Milan or UCSF criteria for that matter. Image-guided ablation is the most frequently used therapeutic strategy, but its efficacy
is limited by the size of the tumor and its localization. Trans arterial Chemoembolization has a survival benefit in patients with
multifocal disease without vascular invasion or extrahepatic spread. Finally, sorafenib, lenvatinib, and regorafenib are the standard
treatments in advanced hepatocellular carcinoma. This lecture gives a brief summary of the scientific evidence that supports the
current recommendations for clinical practice.
gusaguilarruiz@gmail.com